Estimating implant survival in the presence of competing risks

被引:19
|
作者
Biau, David J. [1 ]
Hamadouche, Moussa [2 ]
机构
[1] Univ Paris Diderot, Hop St Louis, Assistance Pub Hop Paris, Dept Biostat & Informat Med, Paris, France
[2] Univ Paris 05, Hop Cochin, Assistance Pub Hop Paris, Dept Chirurg Orthoped, Paris, France
关键词
HIP-ARTHROPLASTY; REPLACEMENT;
D O I
10.1007/s00264-010-1097-2
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
In medical research, commonly, one is interested in the time to the occurence of a particular event, such as the revision of an implant, and the analysis of these data is referred to as survival analysis. However, for some patients, the event is not observed and their observations are censored. These censored observations are particular to survival data and require specific methods for estimation. The Kaplan and Meier method is a popular method to estimate the probability of being free of the event over time and it is now widely applied in orthopaedics such as to report implant survival. However, one of the assumptions underlying the Kaplan-Meier estimator implies that patients whose observations are censored have the same risk of occurrence of the event than patients remaining in the study. However, because the revision of an implant cannot occur after a patient dies, and that dead patients have their observations censored in the Kaplan-Meier method, another setting must be considered. In the sequel we will demonstrate the inadequacy of the Kaplan-Meier method to estimate implant survival and detail the cumulative incidence estimator.
引用
收藏
页码:151 / 155
页数:5
相关论文
共 50 条
  • [41] Comparison of two treatments in the presence of competing risks
    Lyu, Jingjing
    Chen, Jinbao
    Hou, Yawen
    Chen, Zheng
    [J]. PHARMACEUTICAL STATISTICS, 2020, 19 (06) : 746 - 762
  • [42] Estimating sample size in the presence of competing risks - Cause-specific hazard or cumulative incidence approach?
    Tai, B. C.
    Chen, Z. J.
    Machin, D.
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2018, 27 (01) : 114 - 125
  • [43] Comparison of failure probabilities in the presence of competing risks
    Bajorunaite, Ruta
    Klein, John P.
    [J]. JOURNAL OF STATISTICAL COMPUTATION AND SIMULATION, 2008, 78 (10) : 951 - 966
  • [44] Sample size calculations in the presence of competing risks
    Latouche, A.
    Porcher, R.
    [J]. STATISTICS IN MEDICINE, 2007, 26 (30) : 5370 - 5380
  • [45] Joint modelling of longitudinal and survival data in the presence of competing risks with applications to prostate cancer data
    Sheikh, Md Tuhin
    Ibrahim, Joseph G.
    Gelfond, Jonathan A.
    Sun, Wei
    Chen, Ming-Hui
    [J]. STATISTICAL MODELLING, 2021, 21 (1-2) : 72 - 94
  • [46] Joint regression analysis for survival data in the presence of two sets of semi-competing risks
    Peng, Mengjiao
    Xiang, Liming
    [J]. BIOMETRICAL JOURNAL, 2019, 61 (06) : 1402 - 1416
  • [47] Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients
    de Glas, Nienke A.
    Kiderlen, Mandy
    Vandenbroucke, Jan P.
    de Craen, Anton J. M.
    Portielje, Johanneke E. A.
    de Velde, Cornelis J. H. van
    Liefers, Gerrit-Jan
    Bastiaannet, Esther
    Le Cessie, Saskia
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (05)
  • [48] Estimating treatment benefits for the elderly: The effect of competing risks
    Welch, HG
    Albertsen, PC
    Nease, RF
    Bubolz, TA
    Wasson, JH
    [J]. ANNALS OF INTERNAL MEDICINE, 1996, 124 (06) : 577 - 584
  • [49] Multitask Boosting for Survival Analysis with Competing Risks
    Bellot, Alexis
    van der Schaar, Mihaela
    [J]. ADVANCES IN NEURAL INFORMATION PROCESSING SYSTEMS 31 (NIPS 2018), 2018, 31
  • [50] Survival studies: competing risks, immortality and censoring
    Barnett, Adrian G.
    Oldmeadow, Christopher
    Attia, John R.
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2018, 208 (11) : 475 - +